News
The Food and Drug Administration is attempting to phase out petroleum-based synthetic blue, red, yellow, green dyes in favor ...
15m
Stockhead on MSNASX Quarterly Health Wrap: Island completes Phase 2a/b mosquito-borne dengue trialIsland Pharmaeuticals, Dimerix and Tryptamine Therapeutics are among ASX health stocks reporting quarterly results this week.
The FDA approved Botox for migraine headaches in October 2010, giving Allergan clearance to begin marketing its drug to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results